Paediatric Diseases Working Party (PDWP)
Type d'étude:
Numéro de l'étude:
Type de traitement à base de cellules souches:
Maladies:
Non-Hodgkin’s Lymphoma (NHL)
Titre court:
Objectif principal:
The primary end points are: Disease-free and overall survival
Secondary end points are: Incidence of relapse, non-relapse mortality; identification of parameters influencing the outcome of stem cell transplantation in pediatric non-anaplastic PTCL
Secondary end points are: Incidence of relapse, non-relapse mortality; identification of parameters influencing the outcome of stem cell transplantation in pediatric non-anaplastic PTCL
Principaux critères d'inclusion:
- Diagnosis of non-anaplastic peripheral T-cell lymphoma (PTCL) according to the WHO-classification (Campo, Blood 2011), i.e. except of ALK-positive and -negative anaplastic large cell lymphoma (ALCL)
- Age at primary diagnosis of non-anaplastic PTCL < 18 years
- Diagnosis after 1995
- Allogeneic and/or autologous stem cell transplantation
- Age at primary diagnosis of non-anaplastic PTCL < 18 years
- Diagnosis after 1995
- Allogeneic and/or autologous stem cell transplantation
Pays:
Allemagne
Investigateur principal:
Olga Moser
Coordinateur EBMT de l'étude:
Arnaud Dalissier